Maypro introduces EubioQuercetin to North American market
Maypro is introducing EubioQuercetin to the North American market as part of a new distribution partnership with Japan-based Alps Pharmaceutical.
Photo©iStockphoto.com/Bluberries
Maypro (Purchase, NY) is introducing EubioQuercetin to the North American market as part of a new distribution partnership with Japan-based Alps Pharmaceutical. According to the press release, EubioQuercetin is highly absorbable and 6500x more water-soluble than conventional, commercially available quercetin.
“Manufacturers that include EubioQuercetin in their formulations can formulate with a low daily dose of 125 mg for natural anti-aging efficacy compared to conventional quercetin, which requires manufacturers to include quercetin at doses as high as 1,000 mg,” said Isabel Elias-Castro, president of the Maypro Global Nutrition Group, in a press release.
According to Alps Pharmaceutical, EubioQuercetin was developed using a proprietary technology that optimizes 100% of the natural quercetin found in plants, including a unique non-digestible oligosaccharide prebiotic, rutinose.
“We’re happy to partner with Maypro on the North American introduction of our EubioQuercetin ingredient, which we refer to as ‘The World’s First Evolved Prebiotic Quercetin,’” said Osamu Ushimaru, president of Alps Pharmaceuticals. “Without artificial modification, we devised a method to increase the solubility and absorption in the body while maintaining the delivery of Quercetin-Rutinoside to the colon, thereby achieving the combined effects of rutinose and quercetin.”
A potent antioxidant, the company also says that EubioQuercetin, in aqueous solution, has an ORAC score 1,300x greater than conventional quercetin.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
